Michael G. McCully

Michael G. McCully is an accomplished entrepreneur and executive with extensive experience in biotechnology and pharmaceutical industries. As Co-Founder, President, and Chief Operating Officer of Syndeio Biosciences since May 2025, McCully leads efforts in developing precision neurotherapeutics for central nervous system diseases. Previously, as Co-Founder, President, and Chief Executive Officer at Gate Neurosciences from December 2018 to May 2025, McCully played a pivotal role in raising over $90 million and merging with Boost Neurosciences. Other notable roles include President and CEO at Anagin Inc., Managing Director at Terranova Bioventures and RedLeaf Bioventures, and Chief Business Officer at Charleston Laboratories. McCully holds a Master's degree in Biotechnology and Business from Northwestern University and a Bachelor's degree in Plant Molecular Biology from Purdue University.